Clinical Trial Update: Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating prednisone treatment in women with recurrent pregnancy loss or recurrent implantation failure who test positive for antithyr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implantation Failure
• Pregnancy Loss

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy | Conditions: Recurrent Pregnancy Loss, Not Pregnant, Recurrent Implantation Failure | Phase 4 | Status: COMPLETED